Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients

Viral Infections, Non-HIV

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

N Engl J Med.

Woolley AE, Singh SK, Goldberg HJ, Mallidi HR, Givertz MM, Mehra MR, Coppolino A, Kusztos AE, Johnson ME, Chen K, Haddad EA, Fanikos J, Harrington DP, Camp PC, Baden LR, DONATE HCV Trial Team, the DONATE HCV Trial Team

doi: 10.1056/NEJMoa1812406.

Respiratory Tract Infection

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Clin Infect Dis.

Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, Bergeron A, Shoham S, Ljungman P, Waghmare A, Blanchard E, Kim YJ, McKevitt M, Porter DP, Jordan R, Guo Y, German P, Boeckh M, Watkins TR, Chien JW, Dadwal SS

doi: 10.1093/cid/ciz1167.

Viral Infections, Non-HIV

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Lancet Infect Dis.

Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, de Lavallade H, Gallo G, Lehrnbecher T, Engelhard D, Ljungman P, European Conference on Infections in Leukaemia group

doi: 10.1016/S1473-3099(18)30600-5.

Further Publications Anesthesiology

Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial

JAMA

Wilson AM, Clark AB, Cahn T, Chilvers ER, Fraser W, Hammond M, Livermore DM, Maher TM, Parfrey H, Swart AM, Stirling S, Thickett DR, Whyte M, EME-TIPAC team.

doi: 10.1001/jama.2020.22960

Viral Infections, Non-HIV

Covid-19 in solid organ transplant recipients: A single center experience

Transpl Int.

Hoek RAS, Manintveld OC, Betjes MGH, Hellemons ME, Seghers L, van Kampen JAA, Caliskan K, van de Wetering J, van den Hoogen M, Metselaar HJ, Hesselink DA, Rotterdam Transplant Group.

doi: 10.1111/tri.13662.

Bacterial InfectionsFurther Publications Infectiology

Refractory and Resistant Cytomegalovirus after Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

Clin Infect Dis

Sassine J, Khawaja F, Shigle TL, Handy V, Foolad F, Aitken S, Jiang Y, Champlin R, Shpall E, Rezvani K, Ariza-Heredia EJ, Chemaly RF

doi: 10.1093/cid/ciab298

Further Publications Infectiology

Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients

Clin Infect Dis

Perry WA, Paulus JK, Price LL, Snydman DR, Chow JK

doi: 10.1093/cid/ciaa1800

Viral Infections, Non-HIV

Donor graft CMV-serostatus and the risk of arterial and venous thrombotic events in seronegative recipients after non-thoracic solid organ transplantation

Clin Infect Dis.

Belga S, MacDonald C, Chiang D, Kabbani D, Shojai S, Abraldes JG, Cervera C

doi: 10.1093/cid/ciaa125.

Viral Infections, Non-HIV

Outpatient Management of Kidney Transplant Recipients with Suspected COVID-19- Single Center Experience during the New York City Surge

Transpl Infect Dis.

Mehta SA, Leonard J, Labella P, Cartiera K, Soomro I, Neumann H, Montgomery RA, Ali NM

doi: 10.1111/tid.13383.

Related content

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial

Covid-19 in solid organ transplant recipients: A single center experience

Refractory and Resistant Cytomegalovirus after Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients

Donor graft CMV-serostatus and the risk of arterial and venous thrombotic events in seronegative recipients after non-thoracic solid organ transplantation

Outpatient Management of Kidney Transplant Recipients with Suspected COVID-19- Single Center Experience during the New York City Surge